Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Insiders Selling Pfizer And 2 Other Stocks

Published 20/03/2023, 19:42
Updated 20/03/2023, 21:10
© Reuters.  Insiders Selling Pfizer And 2 Other Stocks

© Reuters. Insiders Selling Pfizer And 2 Other Stocks

Benzinga - The Nasdaq Composite traded slightly higher on Monday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Kulicke and Soffa Industries

  • The Trade: Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) Senior Vice President Wong Nelson Munpun sold a total of 5,000 shares at an average price of $53.80. The insider received around $269 thousand from selling those shares.
  • What’s Happening: Kulicke And Soffa Industries reported better-than-expected Q1 EPS results.
  • What Kulicke and Soffa Industries Does: Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices.
Have a look at our premarket coverage here

Jacobs Solutions

  • The Trade: Jacobs Solutions Inc. (NYSE: J) Executive Chair Steven J Demetriou sold a total of 6,666 shares at an average price of $116.77. The insider received around $778.39 thousand from selling those shares.
  • What’s Happening: Jacobs Solutions secured the Consolidated Operations, Management, Engineering & Test (COMET) contract at NASA Kennedy Space Center (KSC).
  • What Jacobs Solutions Does: Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions.
Pfizer
  • The Trade: Pfizer Inc. (NYSE: PFE) SVP and Controller Jennifer B Damico sold a total of 10,272 shares at an average price of $40.08. The insider received around $411.71 thousand from selling those shares.
  • What’s Happening: Pfizer and Astellas Pharma released topline results from the Phase 3 EMBARK trial evaluating Xtandi (enzalutamide) in non-metastatic hormone-sensitive prostate cancer.
  • What Pfizer Does: Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales).
Check This Out: Top 3 Materials Stocks That May Plunge This Quarter

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.